John Bradley Schmieder's most recent trade in Mesa Laboratories, Inc. was a trade of 754 Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 754 | 69,760 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 754 | 0 | - | - | Restricted Stock Units - 7 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 191.31 per share. | 13 Jan 2023 | 1,571 | 68,976 (1%) | 0% | 191.3 | 300,548 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 175.45 per share. | 11 Nov 2022 | 2,500 | 68,976 (1%) | 0% | 175.5 | 438,625 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 431 | 0 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 431 | 71,476 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 754 | 754 | - | - | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 30 | 71,045 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 30 | 30 | - | - | Restricted Stock Units 1 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | 03 Jan 2022 | 1,000 | 2,021 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.78 per share. | 03 Jan 2022 | 1,000 | 72,015 (1%) | 0% | 97.8 | 97,780 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 327.77 per share. | 03 Jan 2022 | 1,000 | 71,015 (1%) | 0% | 327.8 | 327,770 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 431 | 431 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 0 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 71,015 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 278.06 per share. | 11 Aug 2021 | 800 | 70,707 (1%) | 0% | 278.1 | 222,448 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 262.27 per share. | 16 Jun 2021 | 505 | 71,507 (1%) | 0% | 262.3 | 132,446 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 265 | 72,012 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 265 | 0 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 30 | 71,747 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 30 | 60 | - | - | Restricted Stock Units - 1 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 278.23 per share. | 10 Feb 2021 | 1,750 | 71,717 (1%) | 0% | 278.2 | 486,903 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 285.23 per share. | 11 Jan 2021 | 477 | 73,467 (1%) | 0% | 285.2 | 136,055 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 477 | 73,944 (1%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 477 | 0 | - | - | Restricted Stock Units - 3 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2020 | 308 | 308 | - | - | Restricted Stock Unit - 5 | |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | 12 Aug 2020 | 1,429 | 3,021 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Sale of securities on an exchange or to another person at price $ 246.29 per share. | 12 Aug 2020 | 1,429 | 73,467 (1%) | 0% | 246.3 | 351,948 | Common Stock |
| Mesa Laboratories, Inc. | John Bradley Schmieder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.02 per share. | 12 Aug 2020 | 1,429 | 74,896 (1%) | 0% | 72.0 | 102,917 | Common Stock |